Focus Taiwan App
Download

Taiwan says remdesivir doses sufficient as U.S. buys up supply

08/03/2020 06:24 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan has a sufficient stock of the promising COVID-19 drug remdesivir and has found an alternative to the drug if needed, CECC spokesman Chuang Jen-hsiang (莊人祥) said Monday.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.73